974
APPENDIX IX
TABLE IX-1 (
con tin u ed
)
Component
Present Reference
Interval
(Examples)
Present
Unit
Conversion
Factor
SI
Reference
Interval
SI Unit
Symbol
Significant
Digits
Suggested
Minimum
Increment
Mercury (U)—
normal
<30
jltg/24 h
4.985
<150
nmol/d
xxo
10 nmol/d
exposure—
organic
>45
jUg/24 h
4.985
>220
nmol/d
xxo
10 nmol/d
inorganic
>450
^g/24h
0.004985
>2.20
jttmol/d
x.xx
0.01 flmol/d
Metanephrines (U) (as
0-2.0
mg/24 h
5.458
0-11.0
jUmol/d
xx.x
0.5 )imol/d
normetanephrine)
Methanol (P)
0
mg/dL
0.3121
0
mmol/L
XX
1
mmol/L
Methaqualone (P)—
therapeutic
<10
mg/L
3.995
<40
jttmol/L
xxo
10 jUmol/L
toxic
>30
mg/L
3.995
>120
jUmol/L
xxo
10 jttmol/L
Methotrexate (S)—toxic
>2.3
mg/L
2.200
>5.0
)jmol/L
x.x
0.1 jttmol/L
Methsuximide (P) (as
10-40
mg/L
5.285
50-210
umol/L
xxo
10 jltmol/L
desmethylsuximide)—
therapeutic
Methyprylon (P)—
therapeutic
<10
mg/L
5.457
<50
jUmol/L
xxo
10)tmol/L
toxic
>40
mg/L
5.457
>220
jUmol/L
xxo
10 jttmol/L
Beta2-microglobuIin (S)—<50 y
0.80-2.40
mg/L
84.75
68-204
nmol/L
x x x
2 nmol/L
Beta2-microglobulin (U)—<50 y
<140
jUg/24 h
0.08475
<12
nmol/d
XXX
2 nmol/L
Nitrogen, total (U)
Diet
g/24 h
71.38
Diet
mmol/d
xxo
10 mmol/d
Norepinephrine (P)
dependent
215-475 (at rest
pg/mL
0.005911
dependent
1.27-2.81
nmol/L
x.xx
0.01 nmol/L
Norepinephrine (U)
for 15 minutes)
<100
jUg/24 h
5.911
<590
nmol/d
xxo
10 nmol/d
Noretriptyline (P)—therapeutic
25-200
ng/mL
3.797
90-760
nmol/L
xxo
10 nmol/L
Osmolality (P)
280-300
mOsm/kg
1.00
280-300
mmol/kg
XXX
1
mmol/kg
Osmolality (U)
50-1200
mOsm/kg
1.00
50-1200
mmol/kg
XXX
1
mmol/kg
Oxalate (U) (as anhydrous
10-40
mg/24 h
11.11
110-440
jltmol/d
xxo
10 jttmol/d
oxalic acid)
Palmitic acid (Amf)
Depends
mmol/L
1000
Depends
jttmol/L
x x x
5 jitmol/L
Phentobarbital (P)
on gestation
20-40
mg/L
4.419
on gestation
90-170
jtmol/L
XX
5 ^tmol/L
Phénobarbital (P)—therapeutic
2-5
mg/dL
43.06
85-215
ftmol/L
x x x
5 jttmol/L
Phensuximide (P)
4-8
mg/L
5.285
20-40
jUmol/L
XX
5 jtmol/L
Phenylbutazone (P)—therapeutic
<100
mg/L
3.243
<320
jlimoI/L
xxo
10 jttmol/L
Phenytoin (P)
Therapeutic
10-20
mg/L
3.964
40-80
jttmol/L
XX
5 jtmol/L
Toxic
>30
mg/L
3.964
>120
jttmol/L
XX
5 /tmol/L
Phosphate (S) (as phosporus.
2.5-5.0
mg/dL
0.3229
0.80-1.60
mmol/L
x.xx
0.05 mmol/L
inorganic)
Phosphate (U) (as phosphorus,
Diet
g/24 h
32.29
Diet
mmol/d
x x x
1
mmol/d
inorganic)
Phospholipid phosphorus,
dependent
5-12
mg/dL
0.3229
dependent
1.60-3.90
mmol/L
x.xx
0.05 mmol/L
total (P)
Phospholipid phosphorus,
1.2-12
mg/dL
0.3229
0.40-3.90
mmol/L
x.xx
0.05 mmol/L
total (Ere)
Phospholipids (P)—substance
fraction of total
phospholipid
Phosphatidyl choline
65-70
%
of total
0.01
0.65-0.70
1
o.xx
0.01
Phsphatidyl ethanolamine
4-5
%
of total
0.01
0.04-0.05
1
o.xx
0.01
Sphingomyelin
15-20
% of total
0.01
0.15-0.20
1
o.xx
0.01
Lysophosphatidyl choline
3-5
%
of total
0.01
0.03-0.05
1
o.xx
0.01
Phospholipids (Ere)—
substance fraction of
total phospholipid
Phosphatidyl choline
28-33
% of total
0.01
0.28-0.33
1
o.xx
0.01
Phosphatidyl ethanolamine
24-31
%
of total
0.01
0.24-0.31
1
o.xx
0.01
Sphingomyelin
22-29
%
of total
0.01
0.22-0.29
1
o.xx
0.01
Phosphatidyl serine + phos-
12-20
% of total
0.01
0.12-0.20
1
o.xx
0.01
phatidyl inositol
